N@N

ShangPharma to Present at J.P. Morgan Healthcare Conference from January 10 to 13, 2011

^{Published on 2010-12-23 03:41:13 - Market Wire}
 

SHANGHAI--([ BUSINESS WIRE ])--ShangPharma Corporation (NYSE:SHP) ("ShangPharma" or athe Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it will be meeting investors at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco from January 10 to 13, 2011.

Michael Hui, founder and Chief Executive Officer of ShangPharma, and Kevin Chen, Chief Operating Officer and Chief Financial Officer, will host a group presentation at 1:30pm (Pacific Time) on January 12, 2011. The presentation materials will be available under the 'Webcast and Presentation' section of the Company's investor relations website: [ http://ir.shangpharma.com ].

About ShangPharma Corp.

ShangPharma Corporation is a leading China-based contract research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit [ www.shangpharma.com ].